Mariani-Costantini R, Colnaghi M I, Leoni F, Mènard S, Cerasoli S, Rilke F
Virchows Arch A Pathol Anat Histopathol. 1984;402(4):389-404. doi: 10.1007/BF00734636.
The reactivity profile of an IgM monoclonal antibody, MBR1 , raised against the human breast cancer cell line MCF7 , was studied in a variety of human tumours and non-neoplastic tissues by light microscopic immunohistochemistry. The range of reactivity included specific types of non-neoplastic epithelial cells and a number of epithelial tumours. Most mammary carcinomas reacted with MBR1 , but adenocarcinomas and squamous carcinomas from different sites were also strongly positive. Different patterns of immunoreactivity were apparent in microscopically normal tissues, in tissues with inflammatory changes and in carcinomas. Heterogeneous staining, despite morphological similarities, was documented in neoplastic and non-neoplastic epithelial cells. The reactivity of MBR1 was different from that reported for other monoclonal antibodies, but revealed similarities to that of monoclonal antibodies and polyclonal sera against human milk fat globule membrane.
通过光学显微镜免疫组织化学方法,研究了一种针对人乳腺癌细胞系MCF7产生的IgM单克隆抗体MBR1在多种人类肿瘤和非肿瘤组织中的反应谱。其反应范围包括特定类型的非肿瘤上皮细胞和一些上皮性肿瘤。大多数乳腺癌与MBR1发生反应,但来自不同部位的腺癌和鳞癌也呈强阳性。在显微镜下正常组织、有炎症改变的组织和癌组织中,免疫反应模式明显不同。在肿瘤性和非肿瘤性上皮细胞中,尽管形态相似,但均记录到异质性染色。MBR1的反应性与其他单克隆抗体报道的不同,但与针对人乳脂肪球膜的单克隆抗体和多克隆血清的反应性相似。